Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Trader J's Inner Circle -- Ignore unavailable to you. Want to Upgrade?

To: Mike McFarland who wrote (25819)	1/14/2000 10:21:00 AM
From: Mike McFarland	Read Replies (2) \| Respond to of 56535

Had some cash from all those Ariad warrants I sold...don't want to spend it all, but here are the trades: Bought another 1000 SNAP at 7 bought GLIA at 16 1/2 a few days ago, it has traded as low as 14 since that time and I've added a little. Others I've added to-- AXPH and GENXY have lagged the big sequencing company Celera, just posted my frustration with that on the Burke thread, will see if I get any feedback. I'm not ready to quit on these ideas, well obviously or I wouldn't have rolled the Ariad profits into them again--but I'm not as sure of these two picks as I used to be. Oh, I should give some reasons--those last two biotechs should be fairly obvious, cheaper genomic plays. That Synaptic is a value stock, if there is such a thing in biotech, not too far from book value and the company is so damn quiet you know there is zero biotech hype premium. Gliatech is a favorite of too many of the biotech enthusiasts here on SI for me to ignore--and you can even slog through the whole thread and learn something while you trade it!